Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus
US6365394B1 · kind B1 · utility
109Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2000 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | Sep 11, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10352
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel cell lines useful for trans-complementing E1-deleted adenoviral vectors are described. The cell lines are capable of providing high yields of E1-deleted adenoviral vectors in the absence of replication-competent adenovirus over multiple passages.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.